- ADMA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
ADMA Biologics (ADMA) S-8Registration of securities for employees
Filed: 22 Jul 22, 4:31pm
Security type | Security class title | Fee calculation or carry forward rule | Amount registered(2) | Proposed maximum offering price per unit | Maximum aggregate offering price | Fee rate | Amount of registration fee | Carry forward form type | Carry forward file number | Carry forward initial effective date | Filing fee previously paid in connection with unsold securities to be carried forward | |||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share to be issued pursuant to the 2022 Equity Compensation Plan | 457(c) | 18,000,000 | $2.19 | $39,420,000.00 | 0.0000927 | $3,654.24 | ||||||||||||||||||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||
Total Offering Amounts | $39,420,000.00 | $3,654.24 | ||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||||||||||||||
Net Fee Due | $3,654.24 |
(1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, $0.0001 par value per share (the “Common Stock”) that become issuable under the plan set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant’s Common Stock. |
(2) | Calculated pursuant to Rule 457(c) of the Securities Act, solely for the purpose of computing the registration fee, based upon the average of the high and low selling prices of the Common Stock on July 18, 2022, as reported on the Nasdaq Global Market, under the symbol “ADMA”. |